Serious toxicity associated with continuous nevirapine-based HAART in pregnancy.


OBJECTIVE This study was designed to determine the safety of nevirapine (NVP)-based highly active antiretroviral therapy (HAART) in a cohort of HIV-positive pregnant women. DESIGN This was a prospective cohort study of HIV-positive pregnant women. POPULATION AND SETTING All HIV-positive women treated with HAART during pregnancy from January 1997 to… (More)
DOI: 10.1111/j.1471-0528.2008.01820.x


  • Presentations referencing similar topics